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Bovine erythropoietic protoporphyria (EPP) 1 is a  recessively inherited disorder of 
porphyrin metabolism characterized clinically by cutaneous photosensitivity to wave- 
lengths of light  in  the  long ultraviolet  range  and characterized  biochemically by 
elevated  concentrations  of free  protoporphyrin  IX  in  erythrocytes and  feces  (1). 
Ferrochelatase activity is decreased in all bovine tissues examined, e.g., in liver, heart, 
kidney, marrow, etc. to ~ 10% of normal activity in affected homozygous cattle, and 
to 50% in heterozygous cattle that are clinically unaffected (1). The recessive mode of 
inheritance of EPP in cattle differs from human EPP, in which inheritance is clearly 
autosomal dominant in nature. 
It  has  been  reported  that  cultured  skin  fibroblasts  (2)  or  mitogen-stimulated 
lymphoeytes (3)  from  human  patients  with  EPP  accumulate  greater  amounts  of 
protoporphyrin  IX  than  normal  cells when  incubated  with 8-aminolevulinic acid 
(ALA), reflecting the inherited deficiency of ferrochelatase activity. In this study, we 
report that excessive protoporphyrin IX accumulation takes place also in skin fibro- 
blasts from cattle homozygous for the EPP gene defect when cells are incubated with 
ALA. In addition, skin fibroblasts from cattle heterozygous for the EPP gene defect 
accumulate  intermediate levels  of protoporphyrin  IX  from  ALA.  These  findings 
indicate that the basic enzymatic defect underlying the bovine EPP disorder, i.e., a 
deficiency of ferrochelatase activity, can be  functionally demonstrated in cultured 
skin  fibroblasts  from  affected  cattle,  and  that  the  extent  of protoporphyrin  IX 
accumulation is  proportional  to  the  dose of the abnormal  gene  for ferrochelatase 
activity. 
Materials and Methods 
Skin  Fibroblast  Cultures.  Fibroblast  cultures  were  established  from  skin  biopsy  specimens 
obtained from six normal animals, three calves homozygous for the EPP gene defect, and four 
obligatory carriers of EPP.  Skin specimens  (~30 mm  a)  were cut  into small pieces  (1-2 mm  3) 
* Supported in part by grants ES-01055 and AM- 12466 from the U. S. Public Health Service and grant 
1-350 from the National Foundation. 
l Abbreviations used in this paper: ALA, 8-aminolevulinic acid; FBS, fetal bovine serum; Fe, ferric citrate; 
EPP, erythropoietic protoporphyria. 
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and 5-8 pieces were placed in a 25-cm  2 flask in 5 ml of  a modified F12 medium (4) supplemented 
with  20%  fetal bovine serum  (FBS).  Cultures were incubated at  37°C in an atmosphere of 
humidified air with  5% CO~. Growth of fibroblasts was obvious by microscopic observation 
within 1 wk of incubation, and cells were then subcultured every 10 d by a standard technique 
(5). 
Porphyrin Determination.  The  capacity  of skin  fibroblasts  in  culture  to  convert  ALA to 
porphyrins was studied  as follows.  Fibroblasts  grown in a  25-era  2 flask were subcultured  as 
described above and 5 ×  105 cells were placed into each  1.8-era 2 well  of a  FB16-24TC plate 
(Linbro Chemical Co. Inc., Hamden, Conn.) with 0.5 ml of the modified F12-20%  FBS. Cells 
proliferated to confluency within 4 d of incubation. After an additional 2 d of incubation in 
fresh medium, the medium was removed, and the adherent cells were rinsed with serum-free 
modified  F12  medium,  and  1 ml  of serum-free  modified  F12  medium  supplemented  with 
bovine crystalline insulin (1 #g/ml) was added. ALA (0.6-3 raM) was also added to the growth 
medium and incubation was then continued for 24 h at 37°C in a mixture of 5% CO2 and 95% 
air. In some cultures, CaMg EDTA (2.5-10 mM) and ferric citrate (ICe; 0.03-0.06 mM) were 
added before this incubation in addition to ALA. After incubation, the medium was removed 
and the cells were washed once with  1 ml of Earle's buffer. 500 #! of a  1 N  perchloric acid: 
methanol  (1:1)  mixture was added to cells to extract porphyrins. After 5 min, the perchloric 
acid:methanol  solution  was  transferred  to a  6-  ×  50-mm  glass  tube  and  fluorescence was 
measured using a microcell holder designed for a Perkin-Elmer MPF fluorometer (Perkin-Elmer 
Corp., Instrument Div., Norwalk, Conn.)  as described previously (5). Protein concentrations 
were determined by the method of Lowry et al.  (6) on the perehloric acid:methanol residue 
after digestion with 200 #1 of 0.5 N NaOH at 60°C for 1 h. Crystalline bovine serum albumin 
was used as standard. Porphyrin formation was expressed as picomoles of protoprophyrin IX/ 
1 mg protein in 24 h. Phenol red was omitted from the culture media and Earle's buffer because 
it interferes with the porphyrin fluorescence assay. 0.1 M CaMg EDTA was prepared by adding 
the solution containing stoichiometric amounts of CaCI2 and MgCl2 to EDTA solution while 
maintaining the pH of the mixture between 7 and 8, and was filtered through a 0.45-# Millipore 
membrane filter (Millipore Corp., Bedford, Mass.) before use. 
Results 
Skin  fibroblasts  from  cattle  that  were  normal  (+/+),  heterozygous  (+/e),  or 
homozygous (e/e) for the EPP gene defect did not contain detectable porphyrins after 
incubation in culture with the growth medium alone. However, when incubated with 
ALA, these cells accumulated significant quantities of porphyrins (Fig.  1). Fibroblasts 
of all  genotypes  (+/+,  +/e,  and e/e)  accumulated  porphyrins  in  a  dose-dependent 
manner when ALA was added to the medium. In all instances, fluorescence emission 
spectra were characteristic of free protoporphyrin IX (7). In contrast to normal human 
skin  fibroblasts  that,  when  incubated  with  ALA, accumulated  500  pmol  protopor- 
phyrin IX/rag protein  in 24 h  (5), normal bovine skin fibroblasts accumulated only 
~50 pmol protoporphyrin  IX/mg  protein  in 24 h  under the same conditions.  This 
suggests that the enzymatic steps from ALA to the formation of protoporphyrin IX 
are less active or, more likely, that ferrochelatase is more active in normal bovine skin 
fibroblasts than in normal human skin fibroblasts. 
In contrast  to  low  levels  of protoporphyrin  IX observed  in  normal  bovine  skin 
fibroblasts incubated with ALA, skin fibroblasts from e/e cells accumlated a maximum 
of ~300  pmol  protoporphyrin  IX/mg  protein.  Cells  from clinically  normal  parent 
cows that  are obligatory heterozygotes for the  EPP  gene defect  accumulated  inter- 
mediate levels of protoporphyrin IX in the presence of ALA (Fig.  1). 
We have reported earlier that CaMg EDTA is a  potent inhibitor of ferrochelatase 
activity. CaMg EDTA effectively inhibits ferrochelatase action by chelating iron but 
does not interfere with cell adhesion in a  number of cell culture systems, such as skin 1096  BOVINE ERYTHROPOIETIC  PROTOPORPHYRIA 
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Fxo.  1.  Protoporphyrin IX accumulation from exogenously added  ALA in cultured bovine skin 
fibroblasts as a function of ALA concentration. Cells were incubated at 37°C for 24 h in a medium 
containing ALA. Extraction and quantitation of protoporphyrin IX were performed as described in 
Materials and Methods. Data are the mean values +  SEM for cell cultures from six normal animals 
(+/+), three animals homozygous for EPP (e/e), and four animals heterozygous for EPP (+/e). 
fibroblasts  (5), mitogen-stimulated lymphocytes (3), and chick embryo hepatocytes 
(4).  In  studies  of human  EPP,  we  have  demonstrated  that  protoporphyrin  IX 
accumulation is markedly increased by CaMg EDTA in human lymphocytes trans- 
formed with mitogens  (3), and that the increase caused by CaMg EDTA is almost 
twofold greater in  mitogen-transformed lymphocytes from normal subjects than  in 
cells from patients with EPP. This suggests that about twice as much ferroehelatase 
is available for inhibition by the chelator in normal mitogen-transformed lymphocytes 
than in EPP cells. 
Effects of CaMg EDTA on protoporphyrin IX formation by bovine skin fibroblasts 
are shown in Table I. Porphyrin accumulation was stimulated by CaMg EDTA in all 
three types of cells in a  dose-dependent fashion and reached a  plateau  of 500-550 
pmol in 24 h at 5 mM CaMg EDTA or higher. This porphyrin level probably reflects 
maximal  inhibition  of ferrochelatase by CaMg  EDTA  and  is  similar  to  maximal 
values observed in human skin fibroblasts incubated with ALA and CaMg EDTA. 
The extent of porphyrin accumulation stimulated by CaMg EDTA was ~ 13-, 5-, and 
2-fold in +/+,  +/e, and e/e cells, respectively. These results suggest that significant 
inhibition of ferrochelatase activity can be brought about by CaMg EDTA, and that 
the amount of ferrochelatase activity that is inhibitable by the chelator is greatest in 
the normal cells, least in the homozygous EPP cells, and intermediate in the hetero- 
zygous EPP cells. 
The effect of adding iron, one ol~the two substrates of ferrochelatase, on porphyrin 
accumulation was also examined in cultured bovine skin fibroblasts. Addition of Fe 
caused significant reduction in protoporphyrin IX accumulation in +/+ and +/e cells 
(Table II), suggesting that iron supplementation facilitated the use of protoporphyrin 
IX for the formation of heine in these cells. The level of protoporphyrin IX in +/e 
cells after treatment with iron was in fact brought into the normal range. This finding SHIGERU SASSA, SAMUEL SCHWARTZ, AND GEORGE RUTH 
TABLE I 
Effect of CaME EDTA on Porphyrin Formation by Bovine Skin Fibroblasts 
Cells  Treatment 
Protoporphyrin 
IX, 
mean -t- SEM 
Ratio to 
ALA 
control 
of in- 
crease in 
proto- 
por- 
phyrin 
IX by 
CaME 
EDTA 
+/+ 
pmol/mg protein 
1.2 mM ALA  42.3 3= 10.2  -- 
1.2  mM ALA 2=  2.5 mM CaMg  379.8:1:65.7  9.0 
EDTA 
1.2  mM  ALA  +  5  mM  CaMg  553.8  + 24.6  13.1 
EDTA 
1.2  mM ALA +  10  mM CaMg  530.3  :t: 49.5  12.5 
EDTA 
1097 
+/e 
1.2 mM ALA  108.3 + 4.7  -- 
1.2  mM ALA +  2.5 mM CaMg  352.5  :t: 66.7  3.3 
EDTA 
1.2  mM  ALA  +  5  mM  CaMg  428.8  :t: 83.7  4.0 
EDTA 
1.2  mM ALA +  10  mM CaMg  513.0  =1= 89.2  4.7 
EDTA 
e/e 
1.2 mM ALA  290.2 :t: 40.8  -- 
1.2  mM ALA +  2.5  mM CaMg  467.2  :t: 75.9  1.6 
EDTA 
1.2  mM  ALA  +  5  mM  CaMg  518.0:1:59.8  1.8 
EDTA 
1.2  mM ALA :1:10  mM CaMg  591.8:1:82.9  2.0 
EDTA 
Cell  cultures  were prepared  and  treated  with  chemicals as  described in 
Materials  and Methods. Protoporphyrin  IX content was determined  fluoro- 
metrically after incubating cells with chemicals for 24 h. 
suggests that there is sufficient ferrochelatase activity in +/+  and  +/e cells that can 
use protoporphyrin  IX when excess iron is supplemented.  In contrast,  the protopor- 
phyrin IX content ofe/e cells incubated with ALA was hardly affected by addition of 
iron, suggesting an almost complete deficiency of ferrochelatase activity in e/e cells. 
We also examined the effect of iron on the level of protoporphyrin IX accumulation 
stimulated by CaMg EDTA. Reduction in the level of protoporphyrin IX formation 
was observed in all three types of cells when iron was added with CaMg EDTA  (Fig. 
2). However, the extent of protoporphyrin IX reduction by added iron in cells treated 
with both ALA and CaMg EDTA was greatest in normal cells, least in EPP cells, and 
intermediate in heterozygous EPP cells (Fig. 2). Again, the rate of protoporphyrin IX 
use thus determined probably reflects the level of ferrochelatase activity in these cells. 1098  BOVINE  ERYTHROPOIETIC  PROTOPORPHYRIA 
TABLE II 
Effect of Fe on Porphyrin Formation by Bovine Skin Fibroblasts 
Cells  Treatment  Protoporphyrin IX 
Percent 
disappear- 
ance of 
protopor- 
phyrin IX 
by Fe 
+/+ 
+It 
de 
1.2 mM ALA 
1.2  mM  ALA  +  0.03 
mM Fe 
1.2  mM  ALA  +  0.06 
mM Fe 
pmol/mg protein 
42.3  or 10.2 
24.3 or 5.0  43,6 
20.6 or 4.9  51.3 
1.2 mM ALA  108.3 or 4.7  -- 
1.2  mM  ALA  +  0.03  33.5=1=11.3  69.1 
mM Fe 
1.2  mM  ALA  +  0.06  26.2 or 9.3  75.8 
mM Fe 
1.2 mM ALA  290.2  °r 40.8  -- 
1.2  mM  ALA  +  0.03  300,5  or 48.0  0 
mM Fe 
1.2  mM  ALA  +  0.06  295.8  or 53.4  0 
mM Fe 
Cell  cultures  wer~  prepared  and  treated  with  chemicals  as  described  in 
Materials  and  Methods.  Protoporphyrin IX content was determined fluoro- 
metrically after incubating cells with chemicals for 24 h. 
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Fro.  2.  Effects of iron on  the  level  of protoporphyrin IX accumulated  in cultured bovine skin 
fibroblasts incubated with ALA and CaMg EDTA. Cells were incubated at  37°C  for 24  h  in a 
medium containing  1.2  mM ALA and  5  mM CaMg EDTA with or without Fe  (30 or 60  #M). 
Other conditions of the assay were the same as described in the legend to Fig.  1. SHIGERU SASSA, SAMUEL SCHWARTZ, AND GEORGE RUTH  1099 
Discussion 
The  results  of this  study  demonstrate  a  deficiency of ferrochelatase activity  in 
cultured  bovine skin  fibroblasts with  the  EPP gene  defect. This was  achieved by 
incubating cells with ALA and by fluorometric assay of the amount of protoporphyrin 
IX formed in these cells. The amount of protoporphyrin IX accumulation appears to 
reflect the dosage of the abnormal EPP gene. 
It  has  been reported that  a  radiometric ferrochelatase assay performed in  vitro 
using  ~Fe  as  the  substrate  can  demonstrate  an  enzymatic  deficiency in  cultured 
human skin fibroblasts from patients with EPP (2, 8, 9). In our hands, this radiometric 
assay,  although  suitable  for  rat  liver  or  chick  embryo  liver  homogenate,  is  not 
sufficiently sensitive or reliable for the use in cultured skin fibroblasts nor in lympho- 
cytes. Alternatively, we found that incubation of skin fibroblasts with ALA generates 
protoporphyrin  IX  in  the  cells  as  a  function  of ALA  concentration  in  a  highly 
reproducible manner and we have accumulated evidence in a number of systems that 
this is a reliable reflection of ferrochelatase activity (3, 4). The addition of ALA to cell 
culture media was originally employed in our laboratory for the detection of uropor- 
phyrinogen-I synthase deficiency in cultured skin fibroblasts (5) or mitogen-stimulated 
lymphocytes  (10)  from  patients  with  acute  intermittent  porphyria  (5),  and  the 
technique has also been successfully applied by Bloomer et al. (2) to the detection of 
the EPP gene defect in human skin fibroblasts. Using the same technique, we have 
also reported the detection of ferrochelatase deficiency in mitogen-stimulated lym- 
phocytes from human patients with EPP (3). 
Bonkowsky et al.  (8) reported that ferrochelatase activity in skin fibroblasts from 
human EPP patients is only 10% of that found in normal control cells when enzyme 
activity was measured by a radiometric method. However, because human EPP is an 
autosomal dominant  disease, patients are heterozygous for a  gene defect, such that 
their ferrochelatase activity would be expected to be 50% of normal. On the basis of 
the extremely low ferrochelatase activity determined by a  radiometric enzyme assay 
in fibroblasts from human EPP cells, Bloomer recently proposed that ferrochelatase 
is a multimer whose function can be greatly inactivated with the mutation of one of 
the subunits of the enzyme (9).  However, our studies of bovine EPP clearly indicate 
that  the extent of protoporphyrin IX accumulation is a  reflection of ferrochelatase 
activity, and that  this is proportional to the dosage of an abnormal gene in bovine 
EPP  (Fig.  1).  A  50%  functional  deficiency, rather  than  90%, of ferrochelatase has 
been reported from this laboratory in human EPP lymphocytes (3). 
Consistent with the deficiency of ferrochelatase activity as assessed functionally by 
protoporphyrin IX accumulation from added ALA, treatment of bovine cells with 
CaMg EDTA, a potent inhibitor of ferrochelatase activity, stimulated protoporphyrin 
IX accumulation in +/+,  +/e, and e/e cells in a decreasing order. This suggests that 
ferrochelatase activity available for the inhibition by the chelator is greatest in +/+ 
cells and lowest in e/e cells. Similar findings were also obtained in mitogen-transformed 
human  lymphocytes from normal and EPP subjects  (3).  Our findings also indicate 
that CaMg EDTA is an efficient inhibitor of ferrochelatase also in cultured bovine 
skin  fibroblasts,  as we  have shown  earlier in  cultured  human  skin  fibroblasts  (5), 
mitogen-transformed  human  lymphocytes  (3),  and  chick  embryo hepatocytes  (4). 
CaMg EDTA does not appear to interfere with the Ca  2+ and Mg2  + balance of cells II00  BOVINE ERYTHROPOIETIC  PROTOPORPHYRIA 
because cellular attachment to the substratum, which is dependent on the supply of 
Ca  2+ and Mg  2+ (11), is not affected by the chelator treatment. 
Another interesting finding in this study is the fact that the treatment of cells with 
Fe can reduce the level of protoporphyrin IX in bovine skin fibroblasts.  Although 
ferrochelatase is  known  to  use  ferrous, but  not  ferric iron,  for incorporation into 
protoporphyrin IX (12), our finding clearly indicates that sufficient amount of Fe is 
reduced to ferrous iron, which  is  then used by the ferrochelatase reaction to form 
heine. Accumulation of protoporphyrin IX in the presence of CaMg EDTA in +/+ 
and +/e cells was reduced considerably to less than 200 pmol protoporphyrin IX/mg 
protein by treatment with Fe, but it remained at 360 pmol/mg protein in e/e cells, a 
finding consistent with pronounced ferrochelatase deficiency in e/e cells. 
In  addition to our earlier report on the  detection of human  patients with  EPP 
disorder using mitogen-stimulated lymphocytes incubated with ALA, the results of 
our present study of bovine EPp demonstrate the usefulness of measuring protopor- 
phyrin IX accumulation from added ALA for the detection of an EPP gene defect in 
cultured bovine skin fibroblasts. 
Summary 
Bovine skin fibroblasts accumulated protoporphyrin IX when incubated in culture 
with the porphyrin-heme precursor, 8-aminolevulinic acid  (ALA). Fibroblasts from 
cattle  homozygous for erythropoietic protoporphyria  (EPP)  and  with  the  clinical 
symptoms  of the  disease  accumulated  approximately  sixfold  greater  amounts  of 
protoporphyrin IX  than  cells from normal  control animals.  Cells  from obligatory 
heterozygous animals, which are clinically normal, accumulated an intermediate level 
of protoporphyrin IX. When these cells were incubated with ALA and CaMg EDTA, 
all types of cells accumulated approximately the same amount of protoporphyrin IX 
(~500 nmol/mg protein), suggesting that ferrochelatase activity was equally low after 
inhibition by treatment with CaMg EDTA in all cells. Thus the ratio of protopor- 
phyrin IX accumulation from ALA in cultures treated with CaMg EDTA compared 
with controls treated with ALA alone was greatest in normal cells, least in EPP cells, 
and intermediate in the heterozygote cells. These findings suggest that the amount of 
protoporphyrin  IX  accumulation  from  ALA  reflects  the  extent  of deficiency of 
ferrochelatase and is proportional to the dosage of abnormal EPP gene in cultured 
fibroblasts. Similarly, stimulation ofporphyrin accumulation by CaMg EDTA reflects 
diminished  ferrochelatase  activity  in  these  ceils.  Thus,  the  results  of this  study 
demonstrate the usefulness of estimating protoporphyrin IX formation from ALA for 
the detection of an EPP gene defect in cultured bovine skin fibroblasts. 
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